OCCABUZZ//
OCCABUZZ// / THE STANDARD
◇ METHODOLOGY · PUBLIC & AUDITABLE

THE OCCABUZZ STANDARD

A rating is a claim about evidence, not enthusiasm.

Most of this field sells narrative — "private", "elite", "vetted" — and asks you to trust the tone. We publish the opposite: the exact rule by which every grade is assigned, the formula that resolves it, a worked example you can check, and the one policy that keeps a rating honest. The confidence of our language is bound to the grade — never louder than the proof allows.

▚ THE AUDIT — THREE LAYERS

Every asset is scored on three independent layers, each 0–100. A thing can have overwhelming evidence and still be useless to you if it does not apply to a healthy operator, or if no one can sustain it. So we grade all three — and refuse to let a strong layer hide a weak one.

E
EVIDENCE

Peer-reviewed human data — sample size, effect size, and trial stage. A mechanism that is established, not merely inferred. This is the ceiling: nothing scores above what the trials actually show.

C
CONTEXT

Does it apply to a healthy apex operator, or only to clinical deficit? A drug proven to fix a disease is not proof for the well. The question is always: proven for whom?

I
IMPLEMENTATION

Does it survive a demanding calendar? A benefit that requires a protocol no one sustains is a benefit that does not happen. Zero-friction beats theoretically-optimal.

∛ THE FORMULA — WHY ONE WEAK LAYER COLLAPSES THE SCORE
calibrated certainty = ∛( E × C × I )

The score is the geometric mean of the three layers, not the average. This is deliberate. An average lets a brilliant marketing story (high Implementation) paper over absent human proof (low Evidence). The geometric mean does not: if any single layer is near zero, the whole score collapses toward zero. A protocol cannot buy back its missing evidence with convenience. A single failed layer collapses the score — by design.

◈ WORKED EXAMPLE — THE FORMULA, EXECUTED
DOSSIER 024· APOLIPOPROTEIN B & LIPOPROTEIN(a)

This is not a diagram of the method — it is the method. The three numbers below are the published audit for this dossier; the result is computed by the exact function the whole compendium uses. Nothing is rounded by hand.

E88
EVIDENCE

apoB causal & actionable — multivariable Mendelian randomization; LDL-C effect reverses to null once apoB is included.

C78
CONTEXT

Applies to the healthy operator: this is prevention, measured before disease — not a rescue in the already-sick.

I74
IMPLEMENTATION

One cheap blood test; Lp(a) measured once for life. The friction is low, but it needs a physician to act on the number.

∛( 88 × 78 × 74)  = 
80CALIBRATED CERTAINTYGRADE: CLINICAL
↳ AUDIT THE FULL DOSSIER →
◇ THE GRADE LADDER — WHAT A RATING COMMITS US TO
CLINICAL

Demonstrated in humans. Randomized controlled trials or meta-analyses with meaningful sample and effect sizes, and an established mechanism. The strongest grade we publish — and still not a promise.

CONSUMER-VALIDATED

The instrument is proven, the promise is not. A device or sensor validated against a clinical reference (polysomnography, ECG) — but the health outcome the marketing staples to it is a separate, unproven claim. We grade the hardware, not the hope.

EMERGING

Promising but unfinished. Mechanism is plausible and supported by early human or strong preclinical data, but the proof is still narrow — small trials, unmapped safety windows, effects not yet replicated at scale. Published with its limits stated, never hidden.

PRECLINICAL

Mechanism only. Robust in cells or animals, but human outcome evidence is absent or too thin to act on. Published as a frontier signal for informed operators — explicitly not a protocol.

NOT PUBLISHED

The invisible grade. Anything that fails a single audit layer never reaches the grid — however loud the marketing behind it. What we omit is as much a part of the method as what we publish.

⛓ INDEPENDENCE & DISCLOSURE — THE GRADE IS INDEPENDENT OF THE SALE

This is the only fair criticism of any platform that also links to what it rates, so we answer it directly and in public. OCCABUZZ funds its independent research through affiliate relationships on some vetted items. Here is exactly what that does and does not buy:

⧗ WHERE CERTAINTY ENDS — CALIBRATION OVER CERTAINTY

Every dossier states, explicitly, where its certainty ends — the exact point past which the evidence stops and speculation would begin. We publish the ceiling, not just the promise. And because the evidence moves, the grades move: each asset carries a revision history and an audit date, and when new data lands, the score is re-cut in public, on the record. A grade that never changes is a grade that stopped reading.

CALIBRATION OVER CERTAINTY.

▛ ACCOUNTABILITY — A NAMED OPERATOR

A standard with no one behind it is a slogan. This one is engineered and audited by a named, accountable operator — Quene Pereira da Silva, Chief Intelligence Officer. The reasoning is on the page, the sources are linked, and the errors, when they come, are corrected in public.

⁇ COMMON QUESTIONS
How does OCCABUZZ grade the evidence behind a protocol, molecule, or device?

Each asset is scored on three independent 0–100 layers — Evidence (peer-reviewed human data), Context (does it apply to a healthy operator, not only clinical deficit), and Implementation (can it be sustained with zero friction) — then resolved to a calibrated certainty by geometric mean, the cube root of E times C times I. Because it is a geometric mean, a single weak layer collapses the whole score.

Is an OCCABUZZ grade influenced by affiliate or commercial relationships?

No. A grade is assigned on the evidence alone, before any commercial relationship exists, and it does not move because one begins. Affiliate links are disclosed on the page itself; they never buy a higher grade, a softer caveat, or a place in the grid. If a graded item later fails, the grade falls — in public, on the record.

What does a CLINICAL grade mean at OCCABUZZ?

CLINICAL is the strongest grade OCCABUZZ publishes: demonstrated in humans through randomized controlled trials or meta-analyses with meaningful sample and effect sizes, and an established mechanism rather than an inferred one. It is still not a promise — every dossier states exactly where its certainty ends.

What happens to a product that fails the OCCABUZZ audit?

It is not published. Anything that fails a single audit layer never reaches the grid, however loud the marketing behind it. The omission is part of the method: what OCCABUZZ leaves out is as deliberate as what it grades.

Do OCCABUZZ grades change over time?

Yes. Each asset carries a revision history and an audit date. When new evidence lands, the grade is re-cut in public, on the record. A grade that never changes is a grade that stopped reading.

Who is accountable for the OCCABUZZ standard?

The methodology is engineered and audited by a named, accountable operator — Quene Pereira da Silva, Chief Intelligence Officer of OCCABUZZ. The reasoning is shown on each page, the sources are linked, and corrections are made in public.

The public compendium applies this standard to the field. The Operator Dossier applies it to you.

◇ THE COMPENDIUM →THE OPERATOR DOSSIER →

LEGAL & MEDICAL DISCLAIMER — OCCABUZZ is a performance research and curation platform, not a medical organization. Informational and educational purposes only; not evaluated by any regulatory agency; not intended to diagnose, treat, cure, or prevent any disease. Consult a licensed healthcare professional before any protocol.

© 2026 OCCABUZZ // ENGINEERED & AUDITED BY QUENE PEREIRA DA SILVA · CHIEF INTELLIGENCE OFFICER